Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD73 Downregulation Decreases In Vitro and In Vivo Glioblastoma Growth.
Azambuja JH, Gelsleichter NE, Beckenkamp LR, Iser IC, Fernandes MC, Figueiró F, Battastini AMO, Scholl JN, de Oliveira FH, Spanevello RM, Sévigny J, Wink MR, Stefani MA, Teixeira HF, Braganhol E. Azambuja JH, et al. Among authors: beckenkamp lr. Mol Neurobiol. 2019 May;56(5):3260-3279. doi: 10.1007/s12035-018-1240-4. Epub 2018 Aug 16. Mol Neurobiol. 2019. PMID: 30117104
Antitumor action of diphenyl diselenide nanocapsules: In vitro assessments and preclinical evidence in an animal model of glioblastoma multiforme.
Ferreira LM, Azambuja JH, da Silveira EF, Marcondes Sari MH, da Cruz Weber Fulco B, Costa Prado V, Gelsleichter NE, Beckenkamp LR, da Cruz Fernandes M, Spanevello RM, Wink MR, de Cassia Sant Anna Alves R, Nogueira CW, Braganhol E, Cruz L. Ferreira LM, et al. Among authors: beckenkamp lr. J Trace Elem Med Biol. 2019 Sep;55:180-189. doi: 10.1016/j.jtemb.2019.06.010. Epub 2019 Jul 5. J Trace Elem Med Biol. 2019. PMID: 31345356
Nasal Administration of Cationic Nanoemulsions as CD73-siRNA Delivery System for Glioblastoma Treatment: a New Therapeutical Approach.
Azambuja JH, Schuh RS, Michels LR, Gelsleichter NE, Beckenkamp LR, Iser IC, Lenz GS, de Oliveira FH, Venturin G, Greggio S, daCosta JC, Wink MR, Sevigny J, Stefani MA, Battastini AMO, Teixeira HF, Braganhol E. Azambuja JH, et al. Among authors: beckenkamp lr. Mol Neurobiol. 2020 Feb;57(2):635-649. doi: 10.1007/s12035-019-01730-6. Epub 2019 Aug 12. Mol Neurobiol. 2020. PMID: 31407144
Blockade of CD73 delays glioblastoma growth by modulating the immune environment.
Azambuja JH, Schuh RS, Michels LR, Iser IC, Beckenkamp LR, Roliano GG, Lenz GS, Scholl JN, Sévigny J, Wink MR, Stefani MA, Battastini AMO, Figueiró F, Teixeira HF, Braganhol E. Azambuja JH, et al. Among authors: beckenkamp lr. Cancer Immunol Immunother. 2020 Sep;69(9):1801-1812. doi: 10.1007/s00262-020-02569-w. Epub 2020 Apr 29. Cancer Immunol Immunother. 2020. PMID: 32350590 Free PMC article.
CD73 as a target to improve temozolomide chemotherapy effect in glioblastoma preclinical model.
Azambuja JH, Schuh RS, Michels LR, Gelsleichter NE, Beckenkamp LR, Lenz GS, de Oliveira FH, Wink MR, Stefani MA, Battastini AMO, Teixeira HF, Braganhol E. Azambuja JH, et al. Among authors: beckenkamp lr. Cancer Chemother Pharmacol. 2020 Jun;85(6):1177-1182. doi: 10.1007/s00280-020-04077-1. Epub 2020 May 16. Cancer Chemother Pharmacol. 2020. PMID: 32417936
The adenosinergic pathway in mesenchymal stem cell fate and functions.
Galgaro BC, Beckenkamp LR, van den M Nunnenkamp M, Korb VG, Naasani LIS, Roszek K, Wink MR. Galgaro BC, et al. Among authors: beckenkamp lr. Med Res Rev. 2021 Jul;41(4):2316-2349. doi: 10.1002/med.21796. Epub 2021 Mar 1. Med Res Rev. 2021. PMID: 33645857 Review.
20 results